• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胱氨酸病远端肌病和吞咽困难的临床试验准备研究。

Clinical trial readiness study of distal myopathy and dysphagia in nephropathic cystinosis.

机构信息

Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Department of Speech, Language and Swallowing Disorders, Massachusetts General Hospital, Boston, Massachusetts, USA.

出版信息

Muscle Nerve. 2020 Dec;62(6):681-687. doi: 10.1002/mus.27039. Epub 2020 Aug 20.

DOI:10.1002/mus.27039
PMID:32737993
Abstract

BACKGROUND

Nephropathic cystinosis is a lysosomal storage disorder with late-onset systemic complications, such as myopathy and dysphagia. Currently employed outcome measures lack sensitivity and responsiveness for dysphagia and myopathy, a limitation to clinical trial readiness.

METHODS

We evaluated 20 patients with nephropathic cystinosis in two visits over the course of a year to identify outcomes sensitive to detect changes over time. Patients also underwent an expiratory muscle strength training program to assess any effects on aspiration and dysphagia.

RESULTS

There were significant differences in the Timed Up and Go Test (TUG) and Timed 25-Foot Walk (25-FW) between baseline and 1-y follow-up (P < .05). Maximum expiratory pressure (MEP) and peak cough flow (PCF) significantly improved following respiratory training (P < .05).

CONCLUSIONS

Improved respiratory outcomes may enhance patients ability to expel aspirated material from the airway, stave off pulmonary sequelae associated with chronic aspiration, and yield an overall improvement in physical health and well-being.

摘要

背景

遗传性胱氨酸贮积症是一种溶酶体贮积病,伴有晚期全身并发症,如肌病和吞咽困难。目前使用的结局评估方法对吞咽困难和肌病缺乏敏感性和反应性,这限制了临床试验的准备。

方法

我们在一年的时间内对 20 名遗传性胱氨酸贮积症患者进行了两次就诊评估,以确定对随时间变化敏感的结局。患者还接受了呼气肌力量训练计划,以评估对吸入和吞咽困难的任何影响。

结果

在基线和 1 年随访时,计时起立行走测试(TUG)和计时 25 英尺步行测试(25-FW)有显著差异(P <.05)。呼吸训练后最大呼气压力(MEP)和峰值咳嗽流量(PCF)显著改善(P <.05)。

结论

呼吸功能的改善可能增强患者清除气道中吸入物的能力,避免与慢性吸入相关的肺部后遗症,并整体改善身体健康和幸福感。

相似文献

1
Clinical trial readiness study of distal myopathy and dysphagia in nephropathic cystinosis.胱氨酸病远端肌病和吞咽困难的临床试验准备研究。
Muscle Nerve. 2020 Dec;62(6):681-687. doi: 10.1002/mus.27039. Epub 2020 Aug 20.
2
Clinical myopathy in patients with nephropathic cystinosis.胱氨酸病患者的临床肌病。
Muscle Nerve. 2020 Jan;61(1):74-80. doi: 10.1002/mus.26726. Epub 2019 Oct 24.
3
Distal myopathy in nephropathic cystinosis.肾病性胱氨酸病中的远端肌病。
Pediatr Nephrol. 2000 Jan;14(1):36-8. doi: 10.1007/s004670050009.
4
Longitudinal dysphagia assessment in adult patients with nephropathic cystinosis using the Modified Barium Swallow Impairment Profile.应用改良钡吞咽障碍特征分析量表对肾源性胱氨酸病成年患者进行纵向吞咽障碍评估。
Muscle Nerve. 2022 Aug;66(2):223-226. doi: 10.1002/mus.27642. Epub 2022 Jun 10.
5
Distal vacuolar myopathy in nephropathic cystinosis.肾病性胱氨酸病中的远端空泡性肌病
Ann Neurol. 1994 Feb;35(2):181-8. doi: 10.1002/ana.410350209.
6
Swallowing dysfunction in patients with nephropathic cystinosis.胱氨酸病患者的吞咽功能障碍。
Mol Genet Metab. 2019 Apr;126(4):413-415. doi: 10.1016/j.ymgme.2019.01.011. Epub 2019 Jan 22.
7
Respiratory muscle strength training and neuromuscular electrical stimulation in subacute dysphagic stroke patients: a randomized controlled trial.亚急性吞咽困难脑卒中患者的呼吸肌力量训练与神经肌肉电刺激:一项随机对照试验
Clin Rehabil. 2017 Jun;31(6):761-771. doi: 10.1177/0269215516652446. Epub 2016 Jun 7.
8
Cystinosis distal myopathy, novel clinical, pathological and genetic features.胱氨酸病性远端肌病,新的临床、病理和遗传特征。
Neuromuscul Disord. 2017 Sep;27(9):873-878. doi: 10.1016/j.nmd.2017.05.010. Epub 2017 May 15.
9
Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.101例肾病型胱氨酸病患者的吞咽功能障碍:长期半胱胺治疗的益处
Medicine (Baltimore). 2005 May;84(3):137-146. doi: 10.1097/01.md.0000164204.00159.d4.
10
Pulmonary dysfunction in adults with nephropathic cystinosis.成人肾病性胱氨酸病患者的肺功能障碍
Chest. 2001 Feb;119(2):394-401. doi: 10.1378/chest.119.2.394.

引用本文的文献

1
Diagnosis and management of cystinosis: systematic review for a clinical practice guideline.胱氨酸病的诊断与管理:临床实践指南的系统评价
Orphanet J Rare Dis. 2025 Aug 28;20(1):463. doi: 10.1186/s13023-025-03974-z.
2
Gastrointestinal challenges in nephropathic cystinosis: clinical perspectives.遗传性胱氨酸病的胃肠道挑战:临床观点。
Pediatr Nephrol. 2024 Oct;39(10):2845-2860. doi: 10.1007/s00467-023-06211-6. Epub 2024 Feb 23.
3
Health-related quality of life and patient-reported outcome measurements in patients with cystinosis.
胱氨酸病患者的健康相关生活质量和患者报告结局测量
JIMD Rep. 2022 Dec 16;64(2):199-211. doi: 10.1002/jmd2.12352. eCollection 2023 Mar.